These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Oxiracetam in the treatment of multi-infarct dementia and primary degenerative dementia. Dysken MW; Katz R; Stallone F; Kuskowski M J Neuropsychiatry Clin Neurosci; 1989; 1(3):249-52. PubMed ID: 2521069 [TBL] [Abstract][Full Text] [Related]
8. Lorazepam treatment of resistive aggression in dementia. Fritz J; Stewart JT Am J Psychiatry; 1990 Sep; 147(9):1250. PubMed ID: 2386260 [No Abstract] [Full Text] [Related]
9. Glycosaminoglycan polysulfate in old-age dementias: a factor-analytic study of change in psychopathologic symptoms. Morey LC; Ban TA; Cassano G; Santini V; Placidi GF; Modafferi A; Postiglione A Neuropsychobiology; 1988; 19(3):135-8. PubMed ID: 3059221 [TBL] [Abstract][Full Text] [Related]
10. Ateroid in the treatment of dementia: results of a clinical trial. Conti L; Placidi GF; Cassano GB Mod Probl Pharmacopsychiatry; 1989; 23():76-84. PubMed ID: 2469952 [No Abstract] [Full Text] [Related]
11. Pimozide in the treatment of Capgras' syndrome. A case report. Passer KM; Warnock JK Psychosomatics; 1991; 32(4):446-8. PubMed ID: 1961860 [No Abstract] [Full Text] [Related]
12. A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiency. Santini V Mod Probl Pharmacopsychiatry; 1989; 23():95-100. PubMed ID: 2469954 [No Abstract] [Full Text] [Related]
13. Protective effects of Nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. Huang JL; Fu ST; Jiang YY; Cao YB; Guo ML; Wang Y; Xu Z Pharmacol Biochem Behav; 2007 Apr; 86(4):741-8. PubMed ID: 17448528 [TBL] [Abstract][Full Text] [Related]
14. Ateroid in the clinical treatment of multi-infarct dementia. Passeri M; Cucinotta D Mod Probl Pharmacopsychiatry; 1989; 23():85-94. PubMed ID: 2469953 [TBL] [Abstract][Full Text] [Related]
15. Jian Nao Ning for treatment of memory impairment in patients with mild or moderate multi-infarct dementia. Tian J; Yin J; Liu H; Yang C; Wang Y J Tradit Chin Med; 2002 Dec; 22(4):247-51. PubMed ID: 16579082 [TBL] [Abstract][Full Text] [Related]
16. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039 [TBL] [Abstract][Full Text] [Related]
18. [Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia]. Bukatina EE; Grigor'eva IV; Smirnov OV Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):38-42. PubMed ID: 8009931 [TBL] [Abstract][Full Text] [Related]
20. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Cacabelos R; Alvarez XA; Franco-Maside A; Fernández-Novoa L; Caamaño J Ann N Y Acad Sci; 1993 Sep; 695():321-3. PubMed ID: 8239305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]